![](/img/cover-not-exists.png)
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
Jatoi, Aminah, Ritter, Howard L., Dueck, Amylou, Nguyen, Phuong L., Nikcevich, Daniel A., Luyun, Ronnie F., Mattar, Bassam I., Loprinzi, Charles L.Volume:
68
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2009.06.020
Date:
May, 2010
File:
PDF, 361 KB
english, 2010